Manufacturing

Pharma

BMS, generics companies face new suit over Revlimid 'monopoly'

A class action antitrust lawsuit has been filed against BMS and a raft of generic drugmakers for allegedly maintaining a monopoly on Revlimid.
Kevin Dunleavy Nov 22, 2022 11:38am

Fujifilm continues expansion with $188M slotted for cell culture

Nov 22, 2022 10:06am

Rentschler and Oxford are the latest companies swapping out CEOs

Nov 22, 2022 9:00am

After a quiet spell, WuXi Bio is back with another big expansion

Nov 21, 2022 10:55am

Teva has made short work of its hunt for a new CEO

Nov 21, 2022 9:32am

GSK debuts new $33M high-potency Singapore manufacturing plant

Nov 17, 2022 9:30am